The poly-γ-d-glutamic acid capsule surrogate of the Bacillus anthracis capsule induces nitric oxide production via the platelet activating factor receptor signaling pathway

Molecular Immunology
Hae-Ri LeeGi-Eun Rhie

Abstract

The poly-γ-d-glutamic acid (PGA) capsule, a major virulence factor of Bacillus anthracis, confers protection of the bacillus from phagocytosis and allows its unimpeded growth in the host. PGA capsules released from B. anthracis are associated with lethal toxin in the blood of experimentally infected animals and enhance the cytotoxic effect of lethal toxin on macrophages. In addition, PGA capsule itself activates macrophages and dendritic cells to produce proinflammatory cytokine such as IL-1β, indicating multiple roles of PGA capsule in anthrax pathogenesis. Here we report that PGA capsule of Bacillus licheniformis, a surrogate of B. anthracis capsule, induces production of nitric oxide (NO) in RAW264.7 cells and bone marrow-derived macrophages. NO production was induced by PGA in a dose-dependent manner and was markedly reduced by inhibitors of inducible NO synthase (iNOS), suggesting iNOS-dependent production of NO. Induction of NO production by PGA was not observed in macrophages from TLR2-deficient mice and was also substantially inhibited in RAW264.7 cells by pretreatment of TLR2 blocking antibody. Subsequently, the downstream signaling events such as ERK, JNK and p38 of MAPK pathways as well as NF-κB activation were requi...Continue Reading

References

Nov 1, 1991·Annals of Surgery·J B OchoaA B Peitzman
Dec 30, 1993·The New England Journal of Medicine·S Moncada, A Higgs
Jan 1, 1994·Cardiovascular Research·A PetrosP Vallance
Nov 30, 1995·European Journal of Pharmacology·G J SouthanC Thiemermann
May 1, 1997·American Journal of Respiratory and Critical Care Medicine·L LiaudetF Feihl
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·P KovarikT Decker
Dec 14, 1999·Microbes and Infection·S F Little, B E Ivins
Nov 9, 2000·Immunity·M KaraghiosoffM Müller
Jul 18, 2002·The Journal of Clinical Investigation·Stephen H LepplaJoseph Shiloach
Jan 31, 2004·Seminars in Immunology·Kiyoshi Takeda, Shizuo Akira
Mar 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Thomas R KozelC Rick Lyons
Jan 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Konstantin ShatalinEvgeny Nudler
May 5, 2010·Nitric Oxide : Biology and Chemistry·Andrea PautzHartmut Kleinert
Nov 28, 2012·Biochemical and Biophysical Research Communications·Myung-Chul ChungSerguei G Popov
Jun 5, 2013·Frontiers in Cellular and Infection Microbiology·Stephen St JohnSerguei G Popov
Jun 8, 2013·Journal of Cellular and Molecular Medicine·Kenneth Mark CoggeshallShinichiro Kurosawa
Jan 25, 2014·American Journal of Respiratory and Critical Care Medicine·Tom Vanden BerghePeter Vandenabeele
Jan 31, 2014·The Journal of Biological Chemistry·Johanna RiveraDavid L Goldman
Apr 2, 2014·Trends in Microbiology·Shihui LiuStephen H Leppla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.